Statistics
Publications
8
Citations
1.4K
H-Index
8
Active since
1999
Kate A Scott is an author at Cancer Research UK specializing in oncology, life sciences, and inflammation.
Publications per year
1999–2004
8
8
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
Chris J. Scotton, Julia L. Wilson, Kate A Scott et al. · PubMed · 2002 · 479 citations
A chemokine receptor antagonist inhibits experimental breast tumor growth.
Stephen C. Robinson, Kate A Scott, Julia L. Wilson et al. · PubMed · 2003 · 258 citations
Medicine, Oncology, Pharmacology +17
Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development
Caroline H. Arnott, Kate A Scott, Robert J. Moore et al. · Oncogene · 2003 · 207 citations
Medicine, Immunology, Oncology +14
Tumour necrosis factor-α mediates tumour promotion via a PKCα- and AP-1-dependent pathway
Caroline H. Arnott, Kate A Scott, Robert J. Moore et al. · Oncogene · 2002 · 165 citations
Life Sciences, Immunology, Oncology +13
An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors.
Kate A Scott, Robert J. Moore, Caroline H. Arnott et al. · PubMed · 2003 · 150 citations
Medicine, Dermatology, Oncology +12
1–5 of 8